儿童创伤性脑损伤后垂体功能障碍:是否有确切数据?
本文综述已发表的儿童创伤性脑损伤(TBI)后垂体功能减退研究并比较结果,患病率范围为5%至57%,以生长激素(GH)和促肾上腺皮质激素(ACTH)缺乏最常见。儿童研究未能识别发生垂体功能减退的危险因素,无法据此限制仅对重度TBI筛查;综述强调缺乏统一随访且未识别的垂体功能障碍在儿科人群中常见,建议考虑基线筛查并在TBI后6至12个月重新评估。
要点
- 儿童TBI后垂体功能减退患病率报告为5%至57%,GH和ACTH缺乏最常见。
- 儿童研究未识别垂体功能减退的危险因素,无法仅限重度TBI筛查。
- 建议考虑基线筛查并在TBI后6至12个月重新评估垂体功能。
核心结论
- 儿童TBI后垂体功能减退患病率范围为5%至57%,以GH和ACTH缺乏最常见,其次是促性腺激素和促甲状腺激素。
- 儿童研究未能识别发生垂体功能减退的危险因素,因此没有工具将筛查限制在重度TBI。
- 综述强调缺乏统一随访,且未识别的垂体功能障碍在儿科人群中常见。
- 激素替代对患者恢复的影响重要到足以考虑基线筛查并在TBI后6至12个月重新评估。
- 需要更长的前瞻性研究揭示垂体功能障碍的自然病程,并设计新研究检验激素替代对代谢、认知和功能结局的益处。
研究设计与样本
- 本文为综述,回顾并比较已发表的关于儿童TBI后垂体功能减退的研究。
主要发现
- 儿童TBI后垂体功能减退患病率范围为5%至57%。
- GH和ACTH缺乏是最常见的垂体功能减退,其次是促性腺激素和促甲状腺激素缺乏。
- 儿童研究未能识别发生垂体功能减退的危险因素。
- 未识别的垂体功能障碍在儿科人群中常见。
关键数值与推荐
- 国际共识声明建议对TBI幸存者进行随访。
- 考虑基线筛查并在TBI后6至12个月重新评估垂体功能。
临床怎么用
- 医疗界应意识到这些患者存在垂体功能障碍的风险,因为研究中已报告内分泌功能障碍的高患病率。
- 对儿童TBI幸存者考虑基线筛查并在TBI后6至12个月重新评估垂体功能。
局限性
- 儿童研究未能识别发生垂体功能减退的危险因素。
- 目前缺乏统一的随访方案。
- 需要更长的前瞻性研究揭示垂体功能障碍的自然病程。
- 需要新研究检验激素替代对代谢、认知和功能结局的益处。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In the past decade, several studies in adults and children have described the risk of pituitary dysfunction after traumatic brain injury (TBI). As a result, an international consensus statement recommended follow-up on the survivors. This paper reviews published studies regarding hypopituitarism after TBI in children and compares their results. The prevalence of hypopituitarism ranges from 5% to 57%. Growth hormone (GH) and ACTH deficiency are the most common, followed by gonadotropins and thyroid-stimulating hormone. Paediatric studies have failed to identify risk factors for developing hypopituitarism, and therefore we have no tools to restrict screening in severe TBI. In addition, the present review highlights the lack of a unified follow-up and the fact that unrecognised pituitary dysfunction is frequent in paediatric population. The effect of hormonal replacement in patient recovery is important enough to consider baseline screening and reassessment between 6 and 12 months after TBI. Medical community should be aware of the risk of pituitary dysfunction in these patients, given the high prevalence of endocrine dysfunction already reported in the studies. Longer prospective studies are needed to uncover the natural course of pituitary dysfunction, and new studies should be designed to test the benefit of hormonal replacement in metabolic, cognitive and functional outcome in these patients.
引用
- Casano-Sancho P. Pituitary dysfunction after traumatic brain injury: are there definitive data in children? Arch Dis Child. 2016. PMID: 27872046. doi:10.1136/archdischild-2016-311609
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。